Position in AMGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,165,664
+$168,873 QoQ
Shares Held
3,219
+13.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,600
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PERSONAL CFO SOLUTIONS, LLC holds $24,607,939 across 14 Drug Manufacturers - General names. AMGN ranks #8 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,041 | $4,846,897 | |
| 2 | JNJ |
Johnson & Johnson
|
14,929 | $3,791,518 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,511 | $3,149,663 | |
| 4 | NVS |
Novartis AG
|
13,900 | $2,178,408 | |
| 5 | AZN |
Astrazeneca PLC
|
11,123 | $2,109,143 | |
| 6 | ABBV |
AbbVie Inc.
|
7,480 | $1,882,267 | |
| 7 | PFE |
Pfizer Inc
|
66,535 | $1,602,162 | |
| 8 | AMGN |
Amgen Inc
This page
|
3,219 | $1,165,664 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,165,664 | 3,219 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $996,791 | 2,833 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $923,668 | 2,822 | Shares | Defined | 2026-01-22 | |
| 2025-09-30 | $789,031 | 2,796 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $785,417 | 2,813 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $967,985 | 3,107 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $840,564 | 3,225 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,078,114 | 3,346 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $991,716 | 3,174 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $869,734 | 3,059 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $788,886 | 2,739 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $789,079 | 2,936 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $618,769 | 2,787 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $647,164 | 2,677 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $651,609 | 2,481 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $519,321 | 2,304 | Shares | Defined | 2022-11-01 | |
| 2022-06-30 | $545,478 | 2,242 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $534,664 | 2,211 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $483,460 | 2,149 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $408,075 | 1,919 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $466,781 | 1,915 | Shares | Defined | 2021-07-22 | |
| 2021-03-31 | $452,336 | 1,818 | Shares | Defined | 2021-04-21 | |
| 2020-12-31 | $406,268 | 1,767 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $497,136 | 1,956 | Shares | Defined | 2020-11-02 | |
| 2020-06-30 | $362,045 | 1,535 | Shares | Defined | 2020-08-03 | |
| 2020-03-31 | $327,611 | 1,616 | Shares | Defined | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||